Sam Privitera, J.D. has served Chief Technical Officer of AtriCure Inc. since July 2017 leading Research, New Product Development, Manufacturing and Quality Assurance. Prior to joining AtriCure, Mr. Privitera served as Vice President of Research and Development at Bard Medical (“BMD”), a division of C.R. Bard, Inc., where he helped grow BMD to over $1 billion in global revenue. He was responsible for a broad range of clinical platforms including Therapeutic Hypothermia, Urologic Drainage, Endourology, Brachytherapy, and Home Care where they impacted over 150 million patients on an annual basis. Prior to his role at BMD, Mr. Privitera worked for AtriCure as the Vice President of Engineering and Product Development for nine years; during his tenure at AtriCure, the company grew from a small startup into a public company, and he led development of many platform technologies including the AtriClip and CRYO product lines and the PMA approved Isolator® Synergy™ Ablation System. Prior to AtriCure, Mr. Privitera worked at Ethicon Endo-Surgery, a Johnson and Johnson company, in a variety of research, development and operations roles for over twelve years. Since December 2020, Mr. Privitera has served on the Board of Directors of the Cincinnati Chapter of the American Heart Association and is on the Advisory Board for the School of Biomedical Engineering at the State University of New York at Buffalo. Mr. Privitera received his B.S. from the University of Buffalo, his M.B.A. from Xavier University, and his J.D. from Northern Kentucky University; he has over 50 issued US Patents.